Last quarter (Q2 2023), Telesis Bio's total revenue was $8.65M, an increase of 53.00% from the same quarter last year. In Q2, Telesis Bio's net income was $-8.44M. See Telesis Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 31.11M	$ 27.43M	$ 11.04M	$ 6.58M	$ 4.80M
Cost of Revenue	$ 5.76M	$ 11.84M	$ -6.74M	$ 2.95M	$ 2.68M
Gross Profit	$ 19.31M	$ 15.60M	$ 4.30M	$ 3.63M	$ 2.13M
Operating Expense	$ 28.72M	$ 62.08M	$ -39.67M	$ 19.99M	$ 9.10M
Operating Income	$ -38.07M	$ -46.48M	$ -35.37M	$ -16.36M	$ -6.98M
Net Non Operating Interest Income Expense	$ -1.15M	$ -1.22M	$ -1.37M	$ -690.00K	$ -1.49M
Other Income Expense	$ -862.00K	$ 745.00K	$ 680.00K	$ -954.00K	$ 164.00K
Pretax Income	$ -39.83M	$ -48.45M	$ -38.94M	$ -18.00M	$ -8.30M
Tax Provision	$ 19.00K	$ 24.00K	$ 14.00K	$ 5.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -26.81M	$ -48.47M	$ -76.39M	$ -18.01M	$ -8.30M
Basic EPS	$ 448.20	$ -1.65	$ -2.14	$ -0.82	$ -0.39
Diluted EPS	$ 448.20	$ -1.65	$ -2.14	$ -0.82	$ -0.39
Basic Average Shares	$ 118.42M	$ 29.46M	$ 18.22M	$ 21.32M	$ 21.32M
Diluted Average Shares	$ 118.42M	$ 29.46M	$ 18.22M	$ 21.32M	$ 21.32M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 34.48M	$ 73.92M	$ -46.42M	$ 22.94M	$ 11.78M
Net Income From Continuing And Discontinued Operation	$ -39.85M	$ -48.47M	$ -37.44M	$ -18.01M	$ -8.30M
Normalized Income	$ -18.41M	$ -38.27M	-	$ -17.37M	$ -8.36M
Interest Expense	$ 319.00K	-	-	$ 690.00K	$ 1.49M
EBIT	$ -39.02M	$ -48.45M	$ -37.58M	$ -17.32M	$ -6.81M
EBITDA	$ -27.82M	$ -45.09M	$ -35.52M	$ -15.86M	$ -5.96M

Currency in USD

Telesis Bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing